Clinical Study
Male Central Precocious Puberty: Serum Profile of Anti-Müllerian Hormone and Inhibin B before, during, and after Treatment with GnRH Analogue
Table 1
Characteristics of boys with central precocious puberty included in this study.
| | Age at diagnosis (years) | Bone age at diagnosis (years) | Peak LH at diagnosis (U/L) | Peak FSH at diagnosis (U/L) | Etiology | Age at GnRHa start (years) | Age at GnRHa end (years) |
| Patient 1 | 5.5 | 8.5 | 35.30 | 2.10 | Idiopathic | 5.6 | 8.9 | Patient 2 | 4.3 | 8.5 | 6.90 | 0.70 | Hypothalamic hamartoma | 4.8 | 10.3 | Patient 3 | 4.3 | 10.5 | 13.40 | 3.10 | Hypothalamic hamartoma | 4.3 | 9.8 | Patient 4 | 1.7 | 3.6 | 37.00 | 2.30 | Hypothalamic hamartoma | 2.0 | 10.7 | Patient 5 | 1.0 | 1.3 | 32.90 | 7.40 | Idiopathic | 2.2 | N.A | Patient 6 | 0.8 | 2.0 | 84.90 | 1.70 | Idiopathic | 1.1 | 10.0 |
|
|
N.A: not applicable.
|